Proteomics has become an important approach for investigating cellular processes and network functions. Significant improvements have been made during the last few years in technologies for high-throughput proteomics, both at the level of data analysis software and mass spectrometry hardware. As proteomics technologies advance and become more widely accessible, efforts of cataloguing and quantifying full proteomes are underway to complement other genomics approaches, such as RNA and metabolite profiling. Of particular interest is the application of proteome data to improve genome annotation and to include information on posttranslational protein modifications with the annotation of the corresponding gene. This type of analysis requires a paradigm shift because amino acid sequences must be assigned to peptides without relying on existing protein databases. In this review, advances and current limitations of full proteome analysis are briefly highlighted using the model plant Arabidopsis thaliana as an example. Strategies to identify peptides are also discussed on the basis of MS/MS data in a protein database-independent approach.
Introduction
Arabidopsis thaliana has become the plant model organism of choice for which a systems level understanding of complex cellular processes seems to be within reach (Provart and McCourt, 2004) . Global analysis of the system components (DNA, RNA, proteins, metabolites) is now possible, although at different analytical depth at present. High-quality genome sequence information is available for Arabidopsis (Arabidopsis Genome Initiative, 2000) , and based on this information GeneChipsÒ have been developed to analyse the transcriptional activity of most predicted genes. The analysis of all proteins (proteome) and all metabolites (metabolome), however, continues to pose significant challenges. Proteins and metabolites are more diverse and biochemically heterogeneous, which precludes the application of a single standardized procedure for their analysis (reviewed in Aebersold and Mann, 2003; Bino et al., 2004) .
The Arabidopsis genome was the first eukaryotic genome that was entirely represented on TILING arrays (Mockler and Ecker, 2005) . TILING arrays are high density microarrays of oligonucleotides representing the entire genome. In contrast to GeneChipsÒ they also cover regions that are not predicted to possess coding capacity. Two recent studies reported a number of surprising results from full genome TILING arrays using RNA isolated from cultured Arabidopsis cells (Yamada et al., 2003; Stolc et al., 2005) . Both reports showed significant antisense transcription and transcription activity from intergenic regions, suggesting that the transcriptional capacity of the Arabidopsis genome exceeds by far current estimates that are based on genome annotation (Yamada et al., 2003; Stolc et al., 2005) . These exciting results raise the question to what extent antisense transcription regulates the translation rate of a mRNA in vivo and which of the unexpected transcripts from 'non-annotated' intergenic regions are actually translated into proteins and are not just a consequence of transcriptional read-through. It is clear that a detailed and global analysis of all expressed proteins will help to answer these questions and provide urgently needed complementary information about genome structure, activity, and regulation. Proteomics can also provide information about post-translational protein modifications and subcellular localization of the gene product. This type of information is essential to understand better the complex cellular network, for example, the compartmentalization of metabolic pathways and the dependencies between RNA, proteins and metabolites.
Proteomics: novel concepts and expected results
Proteomics has a central role in the systems biology workflow and complements the analysis of the transcriptome and the metabolome. For example, it is currently difficult to predict cellular protein concentrations from the abundance of mRNAs, although several reports found positive correlations between transcript levels and the abundance of subsets of all proteins (Gygi et al., 1999; Ideker et al., 2001; Griffin et al., 2002; Washburn et al., 2003; Kleffmann et al., 2004; Tian et al., 2004 , reviewed in Greenbaum et al., 2003 Hack, 2004) . A positive correlation suggests that transcripts are directly translated into proteins. For many pathways, and especially those that are involved in signalling, protein levels can be regulated independently of transcript levels. Such mechanisms include control of the mRNA translation rate or stability of the protein. In addition, antisense transcription probably contributes significantly to the final concentration of a protein (Yamada et al., 2003; Stolc et al., 2005) .
Development of improved high-throughput proteomics techniques has shifted attention to 'protein profiling', which attempts to identify all proteins that are present in a cell. Protein profiling in high-throughput mode is relatively simple and provides a snapshot of the major protein constituents of the cell (reviewed in Aebersold and Mann, 2003; . Standard protein profiling technologies, however, have two major shortcomings. First, only the most abundant proteins can be detected in a complex protein mixture and, second, the high-throughput analysis is mostly restricted to proteins and peptides in protein databases. Low abundance proteins or proteins translated from alternatively spliced mRNAs that were not predicted correctly, as well as peptides that carry a post-translational modification, will typically escape routine analysis. Despite these drawbacks, protein profiling is an important step towards the systems level analysis of a cell. Desiere and colleagues (2005) suggested using high-throughput proteomics data for the improvement of genome annotation. They used identified, and therefore validated, peptides to improve the genome annotation and to identify splice sites and expressed genome regions that were not predicted to contain protein coding regions. In their analysis, the authors report the unambiguous detection of several SNPs and the confirmation of splice junctions (Desiere et al., 2005) .
Using proteomics data for genome annotations is preferred over expressed sequence tags (EST) and full coding DNA (cDNA) sequences because annotation can be based on identified peptides. Additional information such as, for example, post-translational modifications can be included directly in the genome annotation. Furthermore, proteome analyses of isolated cell organelles will provide information about the subcellular localization of the gene product. Recent large-scale proteome analyses with Arabidopsis chloroplasts (Friso et al., 2004; Kleffmann et al., 2004) , mitochondria , and vacuoles (Carter et al., 2004) suggested that the in silico prediction of protein localization may not be correct for certain proteins and, therefore, protein localization must be verified by additional experiments. Desiere and colleagues (2005) offer an open source platform, called Peptide Atlas, to allow researchers to submit their MS/MS data and make them available for genome annotation by database curators. The collection of data from different sources is an efficient strategy to increase the coverage of the 'peptide-validated' genome. At the current rate of data collection proteome coverage increases linearly with the number of submitted MS/MS data (Desiere et al., 2005) , suggesting that there is still a significant gain of information from each experiment. Although it can be expected that the curve of newly discovered peptides will become saturated as more data are being deposited, this stage has not been reached and data collection is still an efficient strategy to increase proteome coverage.
Protein database-independent amino acid sequence determination from MS/MS data
New genome information obtained from peptides that were identified by MS/MS requires a paradigm shift in proteomics. Until now, high-throughput analyses almost exclusively identified those peptides and proteins that are present in protein databases. Thus, it is currently a prerequisite that a gene has been identified and annotated in the genome prior to proteome analysis. This is a dilemma, because new genome information can be expected only from peptides that are not in the database because they might span regions of unusual splice sites, or because they are derived from unpredicted gene regions or they have an unpredicted posttranslational modification. Thus, when genome information can be improved from validated peptides, it is necessary and important that the peptide amino acid sequence can be extracted directly from the MS/MS spectrum. In principle, two different approaches can be envisioned that can help to reach this ambitious goal. First, MS/MS data are searched against a protein database and those spectra that were left unassigned despite originating from a true peptide must be identified and subjected to a modified database search. This could be a genome database or a protein database search that includes a variety of different post-translational modifications. This strategy requires a database-independent spectrum scoring scheme to identify putative peptidederived spectra and to distinguish them from low quality noise fragmentation or contaminants. Second, the amino acid sequence can be extracted directly from the MS/MS spectrum in a fully database-independent fashion. This is also referred to as 'de novo' sequencing. Both strategies will be discussed briefly and the available tools for such an analysis will be illustrated.
Searching MS/MS data against genome databases is a time-consuming process that requires enormous computational resources and is, therefore, impracticable for most laboratories. Thus, different strategies were devised to narrow the number of MS/MS spectra that must be analysed in such a way. MS/MS spectra are typically scored by heuristic quality parameters to identify those MS/MS spectra that were derived from true peptide fragmentation (Moore et al., 2000; Tabb et al., 2003; Bern et al., 2004; Purvine et al., 2004; Hansen et al., 2005; Nesvizhskii et al., 2005; Xu et al., 2005) . When this is combined with a normal database search, those spectra that were left unassigned by the database search despite a high quality are ideal candidates for modified database searches . This way only a very small subset of the MS/MS spectra must be subjected to a modified database search, therefore allowing for higher search spaces (the time constraint is kept minimal) and for more careful data analysis, including manual data interpretation.
The first step towards database-independent spectrum scoring usually includes the extraction from true peptide MS/MS spectra of those parameters that are characteristic and indicative of peptide fragmentation in collisioninduced dissociation (CID). Several publications have reported such parameters, which are typically dealing with peak height distribution (i.e. intensities of signal peaks compared to noise), overall signal to noise ratio, number of complementing peaks that give rise to the measured parent mass when summed up (i.e. potential b-and y-ions), isotope distribution, number of neutral losses in MS/MS spectra, and the occurrence of amino acid tags. Several implementations of spectra scoring have been released during the last years, assessing all or a subset of the above depicted parameters that are characteristic for true peptide fragmentation (Moore et al., 2000; Tabb et al., 2003; Bern et al., 2004; Purvine et al., 2004; Nesvizhskii et al., 2005; Xu et al., 2005) . A discriminant function is calculated to distinguish between 'good' and 'poor' quality spectra, resulting in an estimate of spectral quality. Only those spectra that are of high quality are then used in a modified database search.
In addition to modified database searches, peptide sequences from an MS/MS spectrum can be determined de novo in a fully database-independent fashion. De novo sequencing tools exclusively use the information in the MS/ MS spectrum to derive an amino acid sequence. Several tools are available and some of them achieve a good quality de novo sequencing result when applied to high quality spectra (Chen et al., 2001; Johnson and Taylor, 2002; Ma et al., 2003; Searle et al., 2004; Zhang, 2004; Fischer et al., 2005; Frank and Pevzner, 2005; Grossmann et al., 2005) . All tools, however, suffer from inherent difficulties with MS/MS spectra that result from inaccurate measurements, missing peaks (gaps), and chemical or instrument noise. Currently employed software tools can provide a probability whether the extracted amino acid sequence is correct and, in addition, assign probabilities to sequence sub-strings. The best performing tools use probabilistic approaches, for example, PepNovo (Frank and Pevzner, 2005) , PEAKS (Ma et al., 2003) , and an HMM-based implementation (Fischer et al., 2005) . PepNovo is publicly available and uses a probabilistic network whose structure reflects the physico-chemical characteristics of peptide fragmentation in CID. PEAKS is a commercial software that computes the best possible peptide sequence for a MS/MS spectrum and provides confidence scores for amino acids in the sequence. The HMM defines a generative model to provide emission probabilities for the suggested amino acid sequence of the observed spectrum. Together, the last few years have seen an enormous improvement in mass spectrometry methods and, particularly, in the software tools to aid the MS/MS spectrum analysis. These parallel developments have now paved the way for the use of high-throughput proteomics data to derive highly reliable, high quality peptide assignments that can be used for genome annotation.
Proteome coverage: current limitations and remedies
Important and novel insights from proteomics data for genome annotation require that proteome analysis reaches a satisfactory depth to enable the annotation of large parts of the genome with validated peptides. To date, most largescale proteome analyses with Arabidopsis were performed with isolated organelles, membrane systems, or subcellular structures (reviewed in Peck, 2005) . These studies include chloroplasts (Peltier et al., 2002 Ferro et al., 2003; Froehlich et al., 2003; Friso et al., 2004; Huber et al., 2004; Kleffmann et al., 2004; Baginsky et al., 2005; reviewed in Baginsky and Gruissem, 2004; van Wijk, 2004) , mitochondria (Brugiere et al., 2004; Lister et al., 2004; Heazlewood et al., 2004,; Millar et al., 2005) , peroxisomes (Fukao et al., 2003) , vacuoles (Carter et al., 2004; Shimaoka et al., 2004) , the plasma membrane (Alexandersson et al., 2004; Ephritikine et al., 2004; Sazuka et al., 2004; Marmagne et al., 2004; Borner et al., 2005 ) the cell wall (Chivasa et al., 2002; Borderies et al., 2003; Boudart et al., 2005) , and cytosolic ribosomes (Chang et al., 2005) . In general, all studies using subcellular organelles reported the identification of proteins that were not predicted to localize to the organelle under investigation when in silico localization prediction tools were used as a benchmark. This suggests that intracellular protein trafficking is more complex than anticipated and that unexpected import routes might exist. It is clear, however, that at the current state of proteome analyses additional experiments are necessary to validate the subcellular localization of proteins. Proteomics data provide an excellent starting point for the design of such experiments.
Most large-scale proteomics analyses in Arabidopsis were designed such that they generally do not allow the identification of post-translational modifications or unusual peptides. Exceptions are those studies that specifically analysed particular post-translational protein modifications. In these instances, the chemical characteristics of the posttranslationally modified peptides or proteins were used for their enrichment and subsequent analysis by MS/MS. This strategy has been successfully employed for the large-scale detection of phosphoproteins from the plasma membrane of Arabidopsis cultured cells. Phosphopeptides were enriched by metal ion affinity chromatography (IMAC) and analysed by MS/MS analysis, which provided information about the phosphorylation site. This comprehensive type of information was used for the assembly of a phosphorylation site database (Nuehse et al., 2003 (Nuehse et al., , 2004 . Another example is the selective isolation of GPI-anchored proteins from the plasma membrane. Here, membrane vesicles were enriched and GPI-anchored proteins specifically released from the membrane by phosphatidylinositol phospholipase C treatment (Borner et al., 2003; Elortza et al., 2003) . Further examples for the directed analysis of specific post-translational modifications are S-nitrosylated proteins (Lindermayr et al., 2005) and redox proteomics based on the search for thioredoxin targets (Marchand et al., 2004) .
The above examples illustrate that a targeted analysis of post-translational modifications is possible. With this type of analysis, however, unexpected post-translational modifications cannot be detected. The lack of comprehensive information is also a shortcoming of routine identification of proteins and peptides. It compounds the problem of reaching high proteome coverage from currently reported proteome information. A large-scale study reported by Giavalisco et al. (2005) was designed to achieve complete proteome coverage of Arabidopsis cells using 2D gel electrophoresis and MALDI-TOF peptide mass fingerprinting. Although the authors used different tissues to broaden the range of protein fractions in order to increase the probability of detecting different proteins, they found only 663 different proteins that originated from 2943 spots. This number of proteins is surprisingly low considering the number of expected proteins in a cell. All subcellular proteome analyses reported to date identified primarily the most highly abundant proteins, sometimes despite sophisticated protein fractionation strategies . Therefore it must be questioned how deep proteome analyses are in practice and what measures can be taken to increase proteome coverage.
Important reasons why certain proteins or peptides escape detection during LC-MS/MS analyses are not just an unusual peptide structure or unanticipated post-translational modifications, but also the effect of 'undersampling' during LC-MS/MS experiments when performed with complex protein mixtures. Liu and colleagues (2004) developed a statistical model, which predicts that as many as 10 LC-MS/MS runs are necessary to reach 95% coverage of all peptides that are theoretically detectable in the mixture. Although runs were performed under the same conditions, each additional run resulted in new peptide identifications (Liu et al., 2004) . Therefore it seems necessary to run a single peptide fraction several times under the same conditions. The 'undersampling' effect can now be reduced by increasing the scan speed with the new generation of ion trap MS/MS instruments. These 'linear traps' contain a mass analyser with an optimized geometry that allows speeding up the duty cycle of each scan considerably. This way, the scan rate is increased, which results in a significant increase in instrument sensitivity and, therefore, allows low abundance peptides to be detected as well. Although the mass spectrometer hardware continues to be improved to achieve higher sensitivities of mass measurements and thus higher proteome coverage, certain limits will remain.
One of the basic limitations is the dynamic range of protein concentrations in a cell, which exceeds the sensitivity of every mass spectrometry device available to date. The currently most-advanced mass spectrometers can handle a dynamic range of 3-5 orders of magnitude. The dynamic range of protein concentrations in a cell, however, is several orders of magnitude higher. Thus, fractionating proteins or peptides prior to the mass spectrometric analysis is necessary to reduce the dynamic range limitations and to increase proteome coverage. New fractionation tools are continuously being developed and it is not within the scope of this review to highlight all of them. In general, multidimensional protein or peptide fractionation (MudPIT) is a preferred strategy to reduce sample complexity prior to analysis of complex mixtures by MS/MS and has recently been expanded to include additional dimensions to increase proteome coverage (Washburn et al., 2001) . In general, reducing the complexity and dynamic range of protein samples prior to analysis is perhaps the most promising and efficient strategy to achieve full (or nearly full) proteome coverage. This strategy should include different fractionation techniques such as MudPIT, 2D PAGE, or free flow electrophoresis together with protein fractions from different tissues or subcellular compartments.
Analysis of a complete proteome remains a challenge despite significant advances in mass spectrometry technology and peptide fractionation tools. Such a challenge can best be tackled by a community effort. Integration of data from different sources will increase the information to expand proteome coverage. Genome annotation based on peptide identification in particular requires an open source platform to collect and integrate MS/MS data. The Peptide Atlas platform (Desiere et al., 2005) has the potential to develop into such an open source platform that will also serve the Arabidopsis community. Many laboratories have already uploaded their data in the SBEAMS database (Systems Biology Experiment Analysis Management System) which is offered by the Institute of Systems Biology in Seattle (www.sbeams.org) and represents a general framework for systems biology experiments. But the open source platform strategy can provide reliable results only if the shared data have the same high quality and reliability. This is presently guaranteed by a standardized data analysis pipeline, which includes statistical tools such as PeptideProphet (Keller et al., 2002; Nesvizhskii et al., 2003) to estimate false positive identification rates prior to genome annotation. The authors are convinced that this strategy is most promising for defining proteomes and achieving a genome coverage that is sufficiently deep. The collective proteome information will serve the community to build better tools for functional genomics and to increase our understanding of biological systems.
